These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12497586)

  • 1. Ribozyme-mediated inhibition of PKCalpha sensitizes androgen-independent human prostate cancer cells to cisplatin-induced apoptosis.
    Orlandi L; Binda M; Folini M; Bearzatto A; Villa R; Daidone MG; Zaffaroni N
    Prostate; 2003 Feb; 54(2):133-43. PubMed ID: 12497586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ribozyme-mediated inhibition of survivin expression increases spontaneous and drug-induced apoptosis and decreases the tumorigenic potential of human prostate cancer cells.
    Pennati M; Binda M; Colella G; Zoppe' M; Folini M; Vignati S; Valentini A; Citti L; De Cesare M; Pratesi G; Giacca M; Daidone MG; Zaffaroni N
    Oncogene; 2004 Jan; 23(2):386-94. PubMed ID: 14724567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemosensitization of human prostate carcinoma cell lines to anti-fas-mediated cytotoxicity and apoptosis.
    Uslu R; Borsellino N; Frost P; Gárban H; Ng CP; Mizutani Y; Belldegrun A; Bonavida B
    Clin Cancer Res; 1997 Jun; 3(6):963-72. PubMed ID: 9815772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel hydroxamic acid compound, BMD188, demonstrates anti-prostate cancer effects by inducing apoptosis. I: In vitro studies.
    Li L; Zhu Z; Joshi B; Porter AT; Tang DG
    Anticancer Res; 1999; 19(1A):51-60. PubMed ID: 10226524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bryostatin 1 induces prolonged activation of extracellular regulated protein kinases in and apoptosis of LNCaP human prostate cancer cells overexpressing protein kinase calpha.
    Gschwend JE; Fair WR; Powell CT
    Mol Pharmacol; 2000 Jun; 57(6):1224-34. PubMed ID: 10825394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a hammerhead ribozyme against BCL-2. II. Ribozyme treatment sensitizes hormone-resistant prostate cancer cells to apoptotic agents.
    Dorai T; Goluboff ET; Olsson CA; Buttyan R
    Anticancer Res; 1997; 17(5A):3307-12. PubMed ID: 9413164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ribozyme-mediated down-regulation of survivin expression sensitizes human melanoma cells to topotecan in vitro and in vivo.
    Pennati M; Binda M; De Cesare M; Pratesi G; Folini M; Citti L; Daidone MG; Zunino F; Zaffaroni N
    Carcinogenesis; 2004 Jul; 25(7):1129-36. PubMed ID: 14764461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation-induced apoptosis of human prostate cancer cells is independent of mutant p53 overexpression.
    Kyprianou N; Rock S
    Anticancer Res; 1998; 18(2A):897-905. PubMed ID: 9615738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutral endopeptidase promotes phorbol ester-induced apoptosis in prostate cancer cells by inhibiting neuropeptide-induced protein kinase C delta degradation.
    Sumitomo M; Shen R; Goldberg JS; Dai J; Navarro D; Nanus DM
    Cancer Res; 2000 Dec; 60(23):6590-6. PubMed ID: 11118039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells.
    Tso CL; McBride WH; Sun J; Patel B; Tsui KH; Paik SH; Gitlitz B; Caliliw R; van Ophoven A; Wu L; deKernion J; Belldegrun A
    Cancer J; 2000; 6(4):220-33. PubMed ID: 11038142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous interleukin 6 is a resistance factor for cis-diamminedichloroplatinum and etoposide-mediated cytotoxicity of human prostate carcinoma cell lines.
    Borsellino N; Belldegrun A; Bonavida B
    Cancer Res; 1995 Oct; 55(20):4633-9. PubMed ID: 7553641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antisense inhibition of protein kinase Calpha reverses the transformed phenotype in human lung carcinoma cells.
    Wang XY; Repasky E; Liu HT
    Exp Cell Res; 1999 Jul; 250(1):253-63. PubMed ID: 10388539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin enhances apoptosis induced by a tumor-selective adenovirus expressing tumor necrosis factor-related apoptosis-inducing ligand.
    Reddy RM; Tsai WS; Ziauddin MF; Zuo J; Cole GW; Maxhimer JB; Fang B; Schrump DS; Nguyen DM
    J Thorac Cardiovasc Surg; 2004 Dec; 128(6):883-91. PubMed ID: 15573073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent membrane translocation of protein kinase C alpha during 12-0-tetradecanoylphorbol-13-acetate-induced apoptosis of LNCaP human prostate cancer cells.
    Powell CT; Brittis NJ; Stec D; Hug H; Heston WD; Fair WR
    Cell Growth Differ; 1996 Apr; 7(4):419-28. PubMed ID: 9052983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
    Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
    Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical antitumor activity of the oral platinum analog satraplatin.
    Wosikowski K; Lamphere L; Unteregger G; Jung V; Kaplan F; Xu JP; Rattel B; Caligiuri M
    Cancer Chemother Pharmacol; 2007 Sep; 60(4):589-600. PubMed ID: 17541592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel titanocene anti-cancer drugs and their effect on apoptosis and the apoptotic pathway in prostate cancer cells.
    O'Connor K; Gill C; Tacke M; Rehmann FJ; Strohfeldt K; Sweeney N; Fitzpatrick JM; Watson RW
    Apoptosis; 2006 Jul; 11(7):1205-14. PubMed ID: 16699961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-induced apoptosis is not necessarily dependent on macromolecular synthesis or proliferation in the p53-negative human prostate cancer cell line PC-3.
    Borner MM; Myers CE; Sartor O; Sei Y; Toko T; Trepel JB; Schneider E
    Cancer Res; 1995 May; 55(10):2122-8. PubMed ID: 7743512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of blocking androgen receptor expression with specific hammerhead ribozyme on in vitro growth of prostate cancer cell line.
    Tong Q; Zhao J; Chen Z; Zeng F; Lu G
    Chin Med J (Engl); 2003 Oct; 116(10):1515-8. PubMed ID: 14570613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exogenous mutant p53 DNA enhanced cisplatin-induced apoptosis in TSGH-8301 human bladder cancer cells.
    Chang FL; Ling YF; Lai MD
    Anticancer Res; 2000; 20(1A):329-36. PubMed ID: 10769676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.